CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$bgne#beigene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that the Company will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 9:50 a.m. ET.
A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of over 8,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor Contact
Kevin Mannix
+1 857-302-5189
ir@beigene.com
Media Contact
Liza Heapes
+1 857-302-5663
media@beigene.com
David Miller is fit again and returns to the South Africa side for the first…
Chilean powerhouse Colo-Colo is pushing to secure its 35th Chilean Primera División title against Ñublense…
Shares of state-run Indian Renewable Energy Development Agency extended their rally for the seventh straight…
Defending champions Pakistan Under-19s defeated arch-rivals India Under-19s by three wickets in a high-stakes Group…
Sunrisers Hyderabad CEO Kaviya Maran and renowned music composer Anirudh Ravichander are set to tie…
ITBP Director General Shatrujeet Kapur confirmed that face-offs with Chinese troops continue at multiple locations…